Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism (HI)

NCT02604485 is registered in ClinicalTrials.gov with XOMA (US) LLC as lead sponsor.

NCT NCT02604485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02604485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism (HI)
Lead sponsor
XOMA (US) LLC
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2015
Completion date
January 31, 2017
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

congenital hyperinsulinism